NYSE:SYK

Stryker - SYK Stock Forecast, Price & News

$276.69

+2.41 (+0.88%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $272.73
▼
$277.15
50-Day Range: $249.54
▼
$283.14
52-Week Range: $188.84
▼
$284.00

Volume: 854,028 shs
Average Volume: 1.33 million shs
Market Capitalization: $104.82 billion

P/E Ratio: 44.84
Dividend Yield: 1.08%
Price Target: $270.79

Institutional Ownership

Stryker MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.63 Rating Score
Upside/Downside: 2.1% Downside
$270.79 Price Target
Short Interest: Healthy
1.49% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -0.95
Upright™ Environmental Score
News Sentiment: 0.55
Based on 10 Articles This Week
Insider Trading: Selling Shares
$97.83 M Sold Last Quarter
Proj. Earnings Growth: 10.38%
From $10.02 to $11.06 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.83 out of 5 stars

Medical Sector

53rd out of 989 stocks

Surgical & Medical Instruments Industry

4th out of 99 stocks

2.3

Analyst's Opinion

Consensus Rating
Stryker has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 12 buy ratings, 7 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $270.79, Stryker has a forecasted downside of 2.1% from its current price of $276.69.
Amount of Analyst Coverage
Stryker has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
1.49% of the float of Stryker has been sold short.
Short Interest Ratio / Days to Cover
Stryker has a short interest ratio ("days to cover") of 4.
Change versus previous month
Short interest in Stryker has recently decreased by 3.33%, indicating that investor sentiment is improving.

4.2

Dividend Strength

Dividend Yield
Stryker pays a meaningful dividend of 1.10%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Stryker has been increasing its dividend for 29 years.
Dividend Coverage
The dividend payout ratio of Stryker is 48.62%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Stryker will have a dividend payout ratio of 27.12% next year. This indicates that Stryker will be able to sustain or increase its dividend.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Stryker has received a 60.46% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Protective clothing", "Synthetic bone grafts", "Surgery simulation software", "Medical laboratory equipment", and "Bone cement" products. See details.
Environmental Sustainability
The Environmental Impact score for Stryker is -0.95.

2.5

News and Social Media Coverage

News Sentiment
Stryker has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Stryker this week, compared to 6 articles on an average week.
Search Interest
53 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 61% compared to the previous 30 days.
MarketBeat Follows
Only 10 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is a decrease of -47% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $97,831,003.00 in company stock.
Percentage Held by Insiders
Only 6.70% of the stock of Stryker is held by insiders.
Percentage Held by Institutions
77.10% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Stryker are expected to grow by 10.38% in the coming year, from $10.02 to $11.06 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Stryker is 44.84, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.64.
Price to Earnings Ratio vs. Sector
The P/E ratio of Stryker is 44.84, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.69.
Price to Earnings Growth Ratio
Stryker has a PEG Ratio of 2.79. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Stryker has a P/B Ratio of 6.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Stryker (NYSE:SYK) Stock

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Stock News Headlines

March 10, 2023 | marketbeat.com

Are These Medical Device Makers Getting Ready To Rally?

Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors.

March 25, 2023 | finance.yahoo.com

Stryker (NYSE:SYK) Could Be A Buy For Its Upcoming Dividend

March 25, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

March 24, 2023 | finance.yahoo.com

3 Dividend Champions for Long-Term Income

March 23, 2023 | americanbankingnews.com

Stryker Co. (NYSE:SYK) Receives $270.79 Average Target Price from Brokerages

March 19, 2023 | americanbankingnews.com

StockNews.com Initiates Coverage on Stryker (NYSE:SYK)

March 8, 2023 | forbes.com

Ukraine’s New Stryker Recon Vehicles Can See Six Miles Away, And Call In Mortars And Missiles

March 7, 2023 | finance.yahoo.com

Navigating Volatility: 3 Stocks Worthy of Consideration

March 25, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

March 7, 2023 | finance.yahoo.com

Stryker Corporation (SYK) Rebounded Strongly in Q4

March 2, 2023 | finance.yahoo.com

Stryker (SYK) Down 6.8% Since Last Earnings Report: Can It Rebound?

March 2, 2023 | finance.yahoo.com

CD NXT power tool system empowers surgeons through real-time depth measurement

February 17, 2023 | finance.yahoo.com

Stryker’s Q Guidance System for cranial applications receives FDA clearance

February 17, 2023 | finance.yahoo.com

Stryker's Q Guidance System Scores FDA Clearance For Cranial Applications

February 15, 2023 | seekingalpha.com

Stryker: Typically Excellent, Typically Expensive

February 12, 2023 | finance.yahoo.com

Should Investors Buy This Dividend Growth Stock?

February 10, 2023 | finance.yahoo.com

Zacks Industry Outlook Highlights Stryker, Zimmer Biomet and Haemonetics

February 9, 2023 | finance.yahoo.com

Stryker declares a $0.75 per share quarterly dividend

February 9, 2023 | seekingalpha.com

Stryker declares $0.75 dividend

February 3, 2023 | finance.yahoo.com

What Makes Stryker (SYK) a New Buy Stock

February 2, 2023 | finance.yahoo.com

Stryker Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

February 1, 2023 | finance.yahoo.com

Stryker Corporation (NYSE:SYK) Q4 2022 Earnings Call Transcript

February 1, 2023 | finance.yahoo.com

Stryker Expects Good Momentum In 2023 Despite Some Volatility

February 1, 2023 | finance.yahoo.com

Stryker's (SYK) Q4 Earnings Beat Estimates, Volume Improves

February 1, 2023 | finance.yahoo.com

Stryker announces 10.7% year-over-year net sales increase

January 31, 2023 | finance.yahoo.com

Stryker reports 2022 operating results and 2023 outlook

January 31, 2023 | finance.yahoo.com

Stryker (SYK) Q4 Earnings and Revenues Top Estimates

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Company Calendar

Ex-Dividend for 1/31 Dividend: 12/29/2022
Last Earnings: 1/31/2023
Dividend Payable: 1/31/2023
Today: 3/25/2023
Ex-Dividend for 4/28 Dividend: 3/30/2023
Next Earnings (Estimated): 4/27/2023
Dividend Payable: 4/28/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:SYK
CUSIP: 86366710
CIK: 310764
Web: www.strykercorp.com
Phone: (269) 385-2600
Fax: 269-385-1062
Employees: 51,000
Year Founded: 1941

Price Target and Rating

Average Stock Price Forecast: $270.79
High Stock Price Forecast: $290.00
Low Stock Price Forecast: $205.00
Forecasted Upside/Downside: -2.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.63
Research Coverage: 19 Analysts

Profitability

EPS (Most Recent Fiscal Year): $6.17
Trailing P/E Ratio: 44.84
Forward P/E Ratio: 27.61
P/E Growth: 2.79
Net Income: $2.36 billion
Net Margins: 12.78%
Pretax Margin: 14.54%
Return on Equity: 22.39%
Return on Assets: 9.85%

Debt

Debt-to-Equity Ratio: 0.71
Current Ratio: 1.63
Quick Ratio: 1.00

Sales & Book Value

Annual Sales: $18.45 billion
Price / Sales: 5.68
Cash Flow: $12.26 per share
Price / Cash Flow: 22.56
Book Value: $43.91 per share
Price / Book: 6.30

Miscellaneous

Outstanding Shares: 378,830,000
Free Float: 353,449,000
Market Cap: $104.82 billion
Optionable: Optionable
Beta: 0.93

Social Links

Key Executives

Kevin A. Lobo
Chairman, President & Chief Executive Officer

Viju S. Menon
Group President-Global Quality & Operations

Glenn S. Boehnlein
Chief Financial Officer & Vice President

Alan Douville
Chief Information Officer & Vice President

Dana S. McMahon
Chief Compliance Officer & Vice President

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SYK Stock - Frequently Asked Questions

Should I buy or sell Stryker stock right now?: 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 7 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SYK shares.
View SYK analyst ratings or view top-rated stocks.
What is Stryker's stock price forecast for 2023?: 19 brokerages have issued twelve-month target prices for Stryker's shares. Their SYK share price forecasts range from $205.00 to $290.00. On average, they predict the company's stock price to reach $270.79 in the next year. This suggests that the stock has a possible downside of 2.1%.
View analysts price targets for SYK or view top-rated stocks among Wall Street analysts.
How have SYK shares performed in 2023?: Stryker's stock was trading at $244.49 at the start of the year. Since then, SYK shares have increased by 13.2% and is now trading at $276.69.
View the best growth stocks for 2023 here.
When is Stryker's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our SYK earnings forecast.
How were Stryker's earnings last quarter?: Stryker Co. (NYSE:SYK) posted its quarterly earnings results on Tuesday, January, 31st. The medical technology company reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.84 by $0.16. The medical technology company had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $4.97 billion. Stryker had a trailing twelve-month return on equity of 22.39% and a net margin of 12.78%. The business's quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter last year, the business earned $2.71 EPS.
How often does Stryker pay dividends? What is the dividend yield for Stryker?: Stryker announced a quarterly dividend on Thursday, February 9th. Shareholders of record on Friday, March 31st will be paid a dividend of $0.75 per share on Friday, April 28th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date of this dividend is Thursday, March 30th.
Read our dividend analysis for SYK.
What ETFs hold Stryker's stock?: ETFs with the largest weight of Stryker (NYSE:SYK) stock in their portfolio include iShares U.S. Medical Devices ETF (IHI), AdvisorShares Focused Equity ETF (CWS), Global X Aging Population ETF (AGNG), 2ndVote Life Neutral Plus ETF (LYFE), Democratic Large Cap Core ETF (DEMZ), Dividend Performers ETF (IPDP), 2ndVote Society Defended ETF (EGIS) and First Trust Indxx Medical Devices ETF (MDEV).
Is Stryker a good dividend stock?: Stryker (NYSE:SYK) pays an annual dividend of $3.00 per share and currently has a dividend yield of 1.10%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 48.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 27.12% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.
What guidance has Stryker issued on next quarter's earnings?: Stryker issued an update on its FY 2023 earnings guidance on Tuesday, January, 31st. The company provided earnings per share guidance of $9.85-$10.15 for the period, compared to the consensus EPS estimate of $9.86. The company issued revenue guidance of -.

What is Kevin A. Lobo's approval rating as Stryker's CEO?: 1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Stryker own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).
What is Stryker's stock symbol?: Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."
Who are Stryker's major shareholders?: Stryker's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Greenleaf Trust (5.19%), Price T Rowe Associates Inc. MD (3.95%), Morgan Stanley (1.58%), Geode Capital Management LLC (1.54%), Fundsmith LLP (1.48%) and Franklin Resources Inc. (1.24%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, James Andrew Pierce, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar, Timothy J Scannell, Viju Menon and William E Berry Jr.
View institutional ownership trends.
How do I buy shares of Stryker?: Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Stryker's stock price today?: One share of SYK stock can currently be purchased for approximately $276.69.
How much money does Stryker make?: Stryker (NYSE:SYK) has a market capitalization of $104.82 billion and generates $18.45 billion in revenue each year. The medical technology company earns $2.36 billion in net income (profit) each year or $6.17 on an earnings per share basis.
How many employees does Stryker have?: The company employs 51,000 workers across the globe.
Does Stryker have any subsidiaries?: The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Vocera Communications, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
How can I contact Stryker?: Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The official website for the company is www.strykercorp.com. The medical technology company can be reached via phone at (269) 385-2600, via email at katherine.owen@stryker.com, or via fax at 269-385-1062.

This page (NYSE:SYK) was last updated on 3/25/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Stryker - SYK Stock Forecast, Price & News

Stryker MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Stryker (NYSE:SYK) Stock

SYK Stock News Headlines

SYK Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

SYK Stock - Frequently Asked Questions

Overall MarketRank^™